{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/stroke-tia/management/suspected-transient-ischaemic-attack/","result":{"pageContext":{"chapter":{"id":"15af1682-8287-57f9-90f1-954c1f71792e","slug":"suspected-transient-ischaemic-attack","fullItemName":"Scenario: Suspected transient ischaemic attack","depth":2,"htmlHeader":"<!-- begin field ee5a46b6-aa51-416c-9cc4-6130320322fc --><h2>Scenario: Suspected transient ischaemic attack</h2><!-- end field ee5a46b6-aa51-416c-9cc4-6130320322fc -->","summary":"Covers the management in primary care of people who present with a history of neurological symptoms that have resolved within 24 hours and suggest TIA.","htmlStringContent":"<!-- begin item 73a4635b-f024-4379-a3b6-5269400d9059 --><!-- begin field 56a6bfb1-b741-44bf-bf62-acbc015b9d30 --><p>From age 16 years onwards.</p><!-- end field 56a6bfb1-b741-44bf-bf62-acbc015b9d30 --><!-- end item 73a4635b-f024-4379-a3b6-5269400d9059 -->","topic":{"id":"f543bb01-4edc-57a6-ba31-aaa6b6b6e6e8","topicId":"63954e32-591d-4f33-bcbb-3fdecfc69796","topicName":"Stroke and TIA","slug":"stroke-tia","lastRevised":"Last revised in August 2020","chapters":[{"id":"3690cd7d-0a6b-548a-a527-b276c3924bab","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"aef0c419-4ee2-52b6-b781-c8afa9a11104","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f8baebfc-07d7-5c4a-8d95-4d2bf1f42c38","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3fa3210c-0be8-5167-adb3-6c05aaef00bc","slug":"changes","fullItemName":"Changes"},{"id":"e606f403-4b76-5e30-a38d-6aa4b6e3b4b1","slug":"update","fullItemName":"Update"}]},{"id":"fe337d01-2447-58d3-93e8-a6b09a4920d4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"08277b76-a6c4-566a-a594-131c32067735","slug":"goals","fullItemName":"Goals"},{"id":"acf4fa85-325c-5018-8bc2-9d877522bf6f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"18bc44dc-3e6b-58ae-9d3c-abca76b13c16","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4eb59f42-29b3-56e1-993f-1ce8ab7b2969","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"08107877-662b-59e6-a30a-b21e19250f23","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ff061807-ab05-5af8-8dd4-01db71526d0f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a0b319c1-8df3-5206-93ce-302f6b981e82","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a0bcd779-defb-50a7-86f6-ab4b2c701ac7","slug":"definition","fullItemName":"Definition"},{"id":"c40d717d-0b67-5cb2-b86c-c67045400115","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"d1569ff2-5da1-51a0-9720-75ad88c0ad86","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"ee8fc150-6899-5c75-a0d0-6241055dfd09","slug":"prevalence","fullItemName":"Prevalence"},{"id":"d5730239-5d67-598b-b9d1-f339079de3eb","slug":"complications","fullItemName":"Complications"},{"id":"9b730ca3-d3ee-552b-8145-f6eadf244a63","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"caea5ae7-0be8-5c7c-8bef-7162c7171e9d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"67902a93-a36b-58c6-a67a-3eb89654460c","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"2bc808d1-f905-575d-90b2-8481eb492905","slug":"assessment","fullItemName":"Assessment"},{"id":"6562a8bf-1396-58ba-b1b9-a1914e4adebe","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"2d634696-3361-5fd3-b676-609f3c31c2f1","fullItemName":"Management","slug":"management","subChapters":[{"id":"1baf2362-0da4-599f-8f9a-12d0124253a0","slug":"suspected-acute-stroke","fullItemName":"Scenario: Suspected acute stroke"},{"id":"15af1682-8287-57f9-90f1-954c1f71792e","slug":"suspected-transient-ischaemic-attack","fullItemName":"Scenario: Suspected transient ischaemic attack"},{"id":"91d820f4-4249-556c-99e2-4ac86d3ebd2a","slug":"secondary-prevention-following-stroke-tia","fullItemName":"Scenario: Secondary prevention following stroke and TIA"},{"id":"84ca3884-d693-5209-b048-6ff53b4ae2be","slug":"management-of-long-term-complications-of-stroke","fullItemName":"Scenario: Management of long term complications of stroke"}]},{"id":"30a83b67-7804-5b41-a647-98d32dce018a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ebfe1dbe-0d9c-5a26-82b4-4d0a308a19ac","slug":"antiplatelet-treatment","fullItemName":"Antiplatelet treatment"}]},{"id":"279444c7-61df-5f92-b512-c703ae6cb9fb","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8ef8b6ac-1d47-5038-b4d7-4d77faf1a823","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"72590587-c86f-5da1-b397-b7e6cc757702","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7ba85ca6-985e-5af5-b223-0c27f7066797","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b322154e-a2d3-59d1-a7b2-d70b4e7812da","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"18f7eefe-52bd-5ad8-a39c-b96d270599ff","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8fed8545-5194-53a4-b547-2d6a402857f5","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"216e65b7-f638-5b35-ad86-30270fbea649","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"2d634696-3361-5fd3-b676-609f3c31c2f1","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"ccbd4a7f-7258-534e-8893-6957bf3f850a","slug":"suspected-tia","fullItemName":"Suspected TIA","depth":3,"htmlHeader":"<!-- begin field d95b16fd-f996-4287-835c-ceb0754e9ac8 --><h3>How should I manage a person with suspected TIA?</h3><!-- end field d95b16fd-f996-4287-835c-ceb0754e9ac8 -->","summary":null,"htmlStringContent":"<!-- begin item 82b1cb10-6ff9-4c77-91cc-642873c7aa93 --><!-- begin field 7e6f6f6c-616d-45c7-9bc3-5c0789f31f57 --><ul><li>If the person has had a suspected TIA within the last week:<ul><li>Give aspirin 300 mg immediately (with proton pump inhibitor cover where appropriate) and arrange urgent assessment (within 24 hours) by a specialist stroke physician <em>unless:</em><ul><li>They have a bleeding disorder or are taking an anticoagulant as haemorrhage requires exclusion — arrange immediate admission for urgent assessment and imaging.</li><li>They are taking low-dose aspirin regularly — continue the current dose of aspirin until reviewed by a specialist.</li><li>Aspirin is contraindicated — discuss management urgently with the specialist team.</li></ul></li><li>Be aware that a person may have ongoing focal neurological deficits despite a negative <a class=\"topic-reference internal-reference\" href=\"/topics/stroke-tia/diagnosis/assessment/\">Fast test</a> and such people must be managed as acute stroke rather than TIA.</li><li>Discuss the need for admission or observation urgently with a stroke specialist if the person:<ul><li>Has had more than one suspected TIA (sometimes known as crescendo TIA).</li><li>Has a suspected cardioembolic source or severe carotid stenosis.</li><li>May be unable to attend for urgent review or lacks a reliable observer at home to contact emergency services if further symptoms occur.</li></ul></li></ul></li><li>If the person has had a suspected TIA which occurred more than a week previously:<ul><li>Refer for specialist assessment as soon as possible within 7 days.</li><li>Assess for atrial fibrillation and other arrhythmias — for more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/atrial-fibrillation/\">Atrial fibrillation</a>.</li></ul></li><li>Give all people with suspected TIA and their family/carers information on the recognition of stroke and TIA and advise them to call 999 immediately if symptoms occur.<ul><li><a data-hyperlink-id=\"8a084299-15dd-4b60-b062-a8f701568f16\" href=\"http://www.stroke.org.uk/shop/information-leaflets\" target=\"_blank\">Patient information</a> is available from the <a data-hyperlink-id=\"e45303f3-d522-40fa-993b-a8f701569026\" href=\"http://www.stroke.org.uk/\" target=\"_blank\">stroke association</a> website at. </li></ul></li><li>Advise the person not to drive until they have been seen by a specialist (when definitive guidance will be given).</li></ul><!-- end field 7e6f6f6c-616d-45c7-9bc3-5c0789f31f57 --><!-- end item 82b1cb10-6ff9-4c77-91cc-642873c7aa93 -->","subChapters":[{"id":"a2d04976-2fcc-5656-95ec-8287ec5c37fe","slug":"basis-for-recommendation-05d","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 12eccf51-c81a-4f33-b37d-d6790f399329 --><h4>Basis for recommendation</h4><!-- end field 12eccf51-c81a-4f33-b37d-d6790f399329 -->","summary":null,"htmlStringContent":"<!-- begin item 05d4e908-2c4c-4ac6-85b1-be2d0c0ff4b1 --><!-- begin field 56a83a2d-8d5f-4215-8b62-f5187bccb2ab --><p>The recommendations on when to refer a person with suspected TIA are based on the clinical guidelines <em>Stroke and transient ischemic attack: acute and long term management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">British Columbia Medical Association, 2015</a>] and <em>National clinical guideline for stroke (prepared by the Intercollegiate Stroke Working Party)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>] and expert opinion in review articles[<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Rothwell et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Hankey, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Sehatzadeh, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Lo, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Rothwell, 2016</a>].</p><h5>Refer anyone with suspected TIA urgently (without risk stratification)</h5><ul><li>TIA is a medical emergency — risk of recurrent stroke is up to 10% in the week following a transient ischaemic attack (TIA) or minor stroke [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Rothwell, 2016</a>]. Immediate diagnosis, secondary preventative treatment and modification of risk factors (for example carotid stenosis) are essential [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Hankey, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Sehatzadeh, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Lo, 2016</a>].<ul><li>Urgent assessment in a specialist clinic ensures timely and appropriate investigation (such as brain imaging) and rapid intervention (such as antiplatelet therapy, blood pressure-lowering medication, statins, anticoagulation and carotid endarterectomy or stenting where appropriate) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Rothwell et al, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Hankey, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>].</li><li>A patient’s 90 day risk of stroke following TIA can be lowered from 12% to approximately 2% with investigation within 24 hours and aggressive management [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">British Columbia Medical Association, 2015</a>].</li><li>Even with the resolution of symptoms, an infarct may have occurred — TIA is a continuum of the same disease process as a stroke [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">British Columbia Medical Association, 2015</a>].</li></ul></li><li>The Intercollegiate Stroke Working Party recommend that people with suspected TIA be assessed and diagnosed urgently without further risk stratification [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Lavallee, 2007</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Wardlaw, 2014</a>] because there is a substantial risk of subsequent stroke in the days following TIA but insufficient evidence on the precision of available risk stratification tools [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>].<ul><li>A systematic review and meta-analysis of 18 independent cohorts (n = 10,126) reporting stroke risk within 7 days of confirmed TIA [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Giles and Rothwell, 2007</a>] found that the risk of completed stroke was much lower if emergency treatment was received in a specialist stroke service (0.9%) compared to a non-urgent setting (11.0%).</li><li>Current risk-stratification tools have not demonstrated an ability to identify individual patients at sufficiently low short-term risk for stroke to be used confidently [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Lo, 2016</a>].</li></ul></li><li>Short term admission or observation of people at particularly high risk of stroke (such as a suspected cardioembolic source or carotid stenosis) or in those unable to attend for urgent review or lacking a reliable observer at home may be needed [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">BMJ Best Practice, 2015c</a>].</li></ul><h5>If symptoms occurred more than a week ago refer less urgently but still to be seen within a week.</h5><ul><li>The Intercollegiate Working Party considers that people presenting with symptoms which have resolved more than a week ago are at lower risk [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>].</li></ul><h5>Treatment while awaiting urgent review</h5><ul><li>The  Intercollegiate Working Party recommends that people whose neurological symptoms have resolved (suggesting a diagnosis of TIA rather than stroke) should be given antiplatelet treatment with aspirin immediately [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Rothwell, 2016</a>].<ul><li>However, they state that evidence on pre-hospital management of suspected stroke or TIA is lacking and most recommendations are based on consensus opinion and accepted practice [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">RCP, 2016</a>].</li></ul></li><li>CKS did not identify any evidence on what to do when TIA occurs in a person already taking aspirin.<ul><li>The recommendation to maintain the current aspirin dose is in line with guidance issued by the American Heart Association and American Stroke Association Council on Stroke, which is based on expert opinion [<a class=\"bibliography-reference internal-reference\" href=\"/topics/stroke-tia/references/\">Furie et al, 2011</a>].</li><li>Feedback from expert reviewers generally recommended that the current dose of aspirin should be continued in people who develop TIA and are already prescribed low-dose aspirin.</li></ul></li></ul><!-- end field 56a83a2d-8d5f-4215-8b62-f5187bccb2ab --><!-- end item 05d4e908-2c4c-4ac6-85b1-be2d0c0ff4b1 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}